I2MC - Institut des maladies métaboliques et cardiovasculaires

Type: Research unit evaluation report

Evaluation campaign: 2019-2020 (group A) - Published on: 17/04/2020

Institution(s) concerned: Institut national de la santé et de la recherche médicale - INSERM , Université Toulouse 3 - Paul Sabatier - UPS

Disciplinary research field: Life and Earth Sciences (SVE) ; SVE5 Physiology, Physiopathology, Cardiology, Pharmacology, Enocrinology, Cancer, Medical Technologies

Scientific field(s): 5 - Biologie, medecine et santé

ERC panel(s): LS4 Physiology, Pathophysiology and Endocrinology: organ physiology, pathophysiology, endocrinology, metabolism, ageing, regeneration, tumorigenesis, cardiovascular disease, metabolic syndrome

Name of unit teams: Adipose tissue, microbiota and cardiometabolic flexibility (DINAMIX) ; Pathophysiology of Metabolic disorders and Diabesity (MetaDiab) ; Lipoproteins and Mitochondrial adaptations in Age-related vascular & metabolic diseases (LiMitAging) ; ESTrogEn Receptor Modulation to prevent aging-related metabolic and vascular dysfunctions (ESTER) ; Molecular regulation of lymphangiogenic factors in cardiovascular diseases ; Cell signalling in arterial stress: impact on cardiovascular diseases (CreateD) ; Lipidomics and signaling in platelet production, thrombosis and cell homeostasis ; Biomarkers, mechanisms and complications of kidney disease ; Cardiometabolic remodeling: mechanisms and microenvironment (CeRAMIC) ; Molecular and clinical determinants of cardiac architecture ; Signaling and pathophysiology of heart failure and aging ; 7 plateaux technologiques : Get Santé, Lipidomique, Cytométrie, Imagerie, Histologie, Bioinformatique, We Met

Keywords: Obesity ; diabetes ; atherosclerosis ; thrombosis ; heart failure ; kidney failure ; NASH ; aging. Metabolism ; signaling ; lipids ; remodeling ; senescence. Endothelium ; platelets ; adipose tissue ; skeletal muscle ; liver ; heart ; kidney ; microbiota